Shi, Y. ., Li, Y. ., Chen, W. ., Zhang, M. ., Qian, D. ., Li, T. ., Dai, Y. . and Li, G. . (2024) “Cost-effectiveness analysis of Sintilimab vs. Docetaxel as the second-line therapy of squamous non-small cell lung cancer in China”, Health Decision, 2(S1). doi: 10.54844/hd.2024.0007.